Infection Clinical Trial
Official title:
Antibiotic Efficacy in Third Molar Surgery
Verified date | July 2010 |
Source | Massachusetts General Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Interventional |
Despite over 50 years of antibiotic use and multiple clinical investigations (>50), no
definitive studies exist to confirm or refute the use of systemic antibiotics to prevent
postoperative inflammatory complications after third molar (M3), aka "wisdom teeth" removal.
Among patients having M3s extracted, does the administration of systemic prophylactic
antibiotics when compared to placebo, decrease the rate of postoperative inflammatory
complications? The first specific aim of the study is to implement a randomized,
placebo-controlled clinical trial to determine if systemic prophylactic antibiotics, when
compared to placebo, decrease the rate of postoperative alveolar osteitis (AO) after M3
extraction. For this proposal, postoperative AO is the primary outcome variable.
The second specific aim is to implement a pilot study using a randomized, placebo-controlled
clinical trial to determine if systemic prophylactic antibiotics, when compared to placebo,
decrease the rate of postoperative infection after M3 extraction. For the purposes of this
proposal, postoperative infection is a secondary outcome variable. Based on sample size
estimates, we believe it will be necessary to implement a multi-year trial to address the
second specific aim definitively. As such, we will use the experience and preliminary
results derived from this clinical trial to develop and implement a future large scale
clinical trial.
The third specific aim is to identify risk factors associated with postoperative
inflammatory complications in order to develop a model to predict if the prophylactic
administration of antibiotics will prevent the postoperative inflammatory complications of
alveolar osteitis and infection following the removal of M3's.
The long-term goal of this project is to provide compelling clinical evidence to support
recommendations regarding the use of systemic antibiotics in this setting and alter clinical
practice based on the results of a well-done, definitive clinical investigation.
Status | Completed |
Enrollment | 132 |
Est. completion date | June 2006 |
Est. primary completion date | June 2006 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 13 Years and older |
Eligibility |
Inclusion Criteria: - Demographics: While all ages are eligible for study enrollment, as a practical matter, most patients having M3s removed are usually > 13-14 years of age. - Gender: Males and females will be offered to participate in this study. - Race: All races and ethnicities are eligible for study enrollment. - Clinical status: at least one impacted mandibular third molar ( M3 ) must be scheduled for extraction. - Anesthesia: Patient request that the procedure be executed using intravenous sedation or general anesthesia. Intravenous sedation will be accomplished with use of an IV placed in the antecubital fossa of each patient - Health status: Healthy patients or patients with mild systemic disease, i.e. ASA status < 3, are eligible for study enrollment. Exclusion Criteria: - Pre-existing infection: Infection is characterised as having an area with frank purulence and/or cellulitis characterized by erythema, induration and inability to open the mouth wide enough to provide access to the airway. - Pre-existing Systemic Illness: as evidenced by severe dry mouth, patients who have undergone radiotherapy for oral cancer, patients that are immunocompromised, patients that require antibiotic prophylaxis for endocarditis, as well as, patients who are taking antimicrobials for other systemic diseases, i.e., uncontrolled diabetes., ASA status > 2. - Allergic Reactions to Medications: Patients who are allergic to Penicillin and Clindamycin will be excluded from the study. - Anesthesia: Patient request that the operation be performed with local anesthesia without intravenous sedation or general anesthesia. - Pregnancy: Pregnancy is a relative contraindication for study enrollment. If after consultation with the obstetrician, there is no contraindication to removing the impacted teeth with sedation or contraindication to receiving the test medications (penicillin or clindamycin) and the patient wants to pursue treatment, she would be considered eligible for study enrollment. |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double-Blind, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United States | Outpatient Clinic for Oral and Maxillofacial Surgery, Wang Pavilion, ACC230 | Boston | Massachusetts |
Lead Sponsor | Collaborator |
---|---|
Massachusetts General Hospital | Oral and Maxillofacial Surgery Foundation, Rosemont ,Illinois |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Presence or absence of postoperative inflammatory complication: i.e., alveolar osteitis or infection | |||
Secondary | Adverse effects from treatment: i.e., antibiotic administration |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04529421 -
Assocation Between In-person Instruction and COVID-19 Risk
|
||
Recruiting |
NCT04081792 -
Optimal Antibiotics for Operated Diabetic Foot Infections
|
N/A | |
Completed |
NCT04332861 -
Evaluation of Infection in Obstructing Urolithiasis
|
||
Recruiting |
NCT04674657 -
Does Extra-Corporeal Membrane Oxygenation Alter Antiinfectives Therapy Pharmacokinetics in Critically Ill Patients
|
||
Enrolling by invitation |
NCT05052203 -
Researching the Effects of Sepsis on Quality Of Life, Vitality, Epigenome and Gene Expression During RecoverY From Sepsis
|
||
Recruiting |
NCT00342589 -
New Techniques for Using a Saline Wash as a Diagnostic Tool for Pneumocystis Pneumonia
|
||
Completed |
NCT03295825 -
Heparin Binding Protein in Early Sepsis Diagnosis
|
N/A | |
Completed |
NCT03296423 -
Bacillus Calmette-guérin Vaccination to Prevent Infections of the Elderly
|
Phase 4 | |
Withdrawn |
NCT04217252 -
Clinical Application of High-throughput Sequencing Technology for the Diagnosis of Patients With Severe Infection
|
N/A | |
Recruiting |
NCT02905552 -
Myelodysplasic Syndromes and Risk Factors for Infection
|
N/A | |
Recruiting |
NCT02899143 -
Short-course Antimicrobial Therapy in Sepsis
|
Phase 2 | |
Withdrawn |
NCT02904434 -
Gastrointestinal Implications of Voriconazole Exposure
|
||
Active, not recruiting |
NCT02768454 -
Antimicrobials Stewardship by Pharmacist
|
N/A | |
Completed |
NCT02219776 -
Decreasing Infection In Arthroscopic Shoulder Surgery
|
N/A | |
Completed |
NCT02210169 -
RCT of Continuous Versus Intermittent Infusion of Vancomycin in Neonates
|
N/A | |
Recruiting |
NCT02098226 -
Evaluation of MALDI Biotyper CA System for Detection of Gram- and Gram+ Bacteria and Yeasts
|
N/A | |
Completed |
NCT01846832 -
A Study of TMC435 Plus Pegylated Interferon Alfa-2a and Ribavirin in Participants With Chronic HCV Infection
|
Phase 3 | |
Completed |
NCT01434797 -
Value of PET/CT Imaging in the Diagnosis of Permanent Central Venous Catheters Infection
|
||
Terminated |
NCT01441206 -
Safety and Pharmacokinetics of Single and Multiple Dose Rifampin in Infants
|
Phase 1 | |
Completed |
NCT01159834 -
Human Papillomavirus (HPV) Vaccination in Barretos (Pio XII Foundation - Barretos Cancer Hospital)
|
N/A |